It is recognized that sustained ischemia-induced hyperactivity is related t
o abnormalities in dopamine function. However, it is unclear that dopaminer
gic neurotransmission triggers such ischemia-induced hyperactivity. Therefo
re, the relationship between dopaminergic neurotransmission and ischemia-in
duced hyperactivity was investigated in an animal model using Mongolian ger
bils. When haloperidol 2 mg/kg was administered i.p. 30 min after ischemia,
the ischemia-induced hyperactivity at 24 h after ischemia was blocked. Gen
eral behavior was similar to that of sham-operated animals. Haloperidol at
doses of 0.1 and 0.2 mg/kg had no effect on locomotor activity in sham-oper
ated animals and decreased ischemia-induced hyperactivity when the drug was
administered 24 h after ischemia; these doses did not have any effect on i
schemia-induced hyperactivity when the drug was administered 30 min after i
schemia. On the other hand, when the animal was confined to a small, restri
ctive cage for the 24 h period immediately following ischemic injury, locom
otor activity at 24 h after ischemia increased. Such behavior also increase
d in animals when they were returned to their original more permissive cage
s immediately after ischemia. It is conceivable that the decrease in the le
vel of activity was not related to ischemia-induced hyperactivity. These da
ta suggested that the inhibition of ischemia-induced hyperactivity can be i
nduced by complete blockage of dopaminergic receptors immediately after isc
hemia.